Perioperative Exhaled Nitric Oxide as an Indicator for Postoperative Pneumonia in Surgical Lung Cancer Patients: A Prospective Cohort Study Based on 183 Cases
Canadian Respiratory Journal · 04.09.2022 · 2022 · 1-8
DOI: 10.1155/2022/9149385 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Canadian Respiratory Journal, erschienen am 04.09.2022. Verfasst von Gui-Xian Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Southwest Medical University, Luzhou 646000, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Sichuan Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
This study is conducted to investigate the correlation between perioperative fractional exhaled nitric oxide and postoperative pneumonia (POP) and the feasibility of perioperative FeNO for predicting POP in surgical lung cancer patients.
Methods
Patients who were diagnosed with non-small-cell lung cancer (NSCLC) were prospectively analyzed, and the relationship between perioperative FeNO and POP was evaluated based on patients’ basic characteristics and clinical data in the hospital.
Results
There were 218 patients enrolled in this study. Finally, 183 patients were involved in the study, with 19 of them in the POP group and 164 in the non-POP group. The POP group had significantly higher postoperative FeNO (median: 30.0 vs. 19.0 ppb, P < 0.001 ) as well as change in FeNO (median: 10.0 vs. 0.0 ppb, P < 0.001 ) before and after the surgery. For predicting POP based on the receiver operating characteristic (ROC) curve, a cutoff value of 25 ppb for postoperative FeNO (Youden’s index: 0.515, sensitivity: 78.9%, and specificity: 72.6%) and 4 ppb for change in FeNO (Youden’s index: 0.610, sensitivity: 84.2%, specificity: 76.8%) were selected. Furthermore, according to the bivariate regression analysis, FEV1/FVC (OR = 0.948, 95% CI: 0.899–0.999, P = 0.048 ), POD1 FeNO (OR = 1.048, 95% CI: 1.019–1.077, P = 0.001 ), and change in FeNO (OR = 1.087, 95% CI: 1.044–1.132, P < 0.001 ) were significantly associated with occurrence of POP.
Conclusions
This prospective study revealed that a high postoperative FeNO (>25 ppb), as well as an increased change in FeNO (>4 ppb), may have the potential in detecting the occurrence of POP in surgical lung cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Southwest Medical University, Luzhou 646000, Sichuan, China.
- Sichuan Cancer Hospital, Chengdu 610041, Sichuan, China.
- Department of Thoracic Surgery, Sichuan Cancer Hospital, Chengdu 610041, Sichuan, China.
ORCID-Profile: Gui-Xian Liu, Jin-Tao He, Xin Wang
Förderung
- Department of Science and Technology of Sichuan Province
Zitieren
APA
Liu, G. X., Yang, Y., Chen, L., Gu, M. Q., He, J. T., & Wang, X. (2022). Perioperative Exhaled Nitric Oxide as an Indicator for Postoperative Pneumonia in Surgical Lung Cancer Patients: A Prospective Cohort Study Based on 183 Cases. Canadian Respiratory Journal, 2022, 1-8. https://doi.org/10.1155/2022/9149385
Vancouver
Liu GX, Yang Y, Chen L, Gu MQ, He JT, Wang X. Perioperative Exhaled Nitric Oxide as an Indicator for Postoperative Pneumonia in Surgical Lung Cancer Patients: A Prospective Cohort Study Based on 183 Cases. Canadian Respiratory Journal. 2022;2022:1-8. doi:10.1155/2022/9149385
BibTeX
@article{Liu2022,
author = {Liu, Gui-Xian and Yang, Yue and Chen, Lei and Gu, Mi-Qi and He, Jin-Tao and Wang, Xin},
title = {Perioperative Exhaled Nitric Oxide as an Indicator for Postoperative Pneumonia in Surgical Lung Cancer Patients: A Prospective Cohort Study Based on 183 Cases},
journal = {Canadian Respiratory Journal},
year = {2022},
volume = {2022},
pages = {1--8},
doi = {10.1155/2022/9149385}
}
EUVIMED